Press Releases

Press Releases

Taro Pharmaceutical Industries Ltd. announced today that it recently completed its $250 million share repurchase program. The company bought back 1,801,099 of its ordinary shares in open market transactions at an average price of $138.80 per share. The repurchase program was announced by the company on March 15, 2016, and…

Press Releases

Mayne Pharma is pleased to announce it has acquired a portfolio of on-market dermatology Foam Assets from GSK for US$50.1 million. The Foam Assets include US rights to Fabior and Sorilux, Canadian rights to Luxiq® and Olux-E® and Mexican rights to betamethasone foam. Under the terms of the agreement Mayne…

Press Releases

Xenetic Biosciences, Inc., a biopharmaceutical company developing next-generation biologic drugs and novel orphan oncology therapeutics, today announced that it has commenced a collaboration with Excivion Ltd. (“Excivion”) to develop a vaccine against Zika and dengue viruses. As part of the collaboration, Xenetic’s proprietary IMUXEN™ Technology will be used to develop…

Press Releases

Remedy Pharmaceuticals, a privately-held phase 3-ready pharmaceutical company focused on bringing life-saving hospital-based treatment to people affected by central nervous system related edema, today announced the successful conclusion of a two-day scientific advisory board meeting in which a distinguished panel of experts provided recommendations on promising indications for the Company…

Press Releases

Evolva has entered into an agreement with a private US biotech venture to develop new production routes for a family of existing active pharmaceutical ingredients (“API”). Evolva will be responsible for the development of the production routes, whilst the partner will be responsible for the registration and commercialisation of the…

Press Releases

Webinar: “IMPACT & Electroceuticals: getting better with electricity Wednesday 7th September 2016 | 10am GMT (UK Time) Presentation 1: IMPACT – Implantable Microsystems for Personalised Anti-Cancer Therapy Presented by Stewart Smith, Lecturer, The University of Edinburgh •    Measuring the microenvironment of a tumour with implanted sensors to inform radiotherapy treatment…

Press Releases

Cytokinetics, Inc. today announced the completion of patient enrollment in VITALITY-ALS (Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices after Treatment for a Year in ALS), an international Phase 3 clinical trial of tirasemtiv in patients with ALS. VITALITY-ALS is designed to assess the effects of tirasemtiv versus placebo…

Press Releases

Janssen Biotech, Inc. announced today a supplemental Biologics License Application (sBLA) for daratumumab (DARZALEX®) has been submitted to the U.S. Food and Drug Administration (FDA). The application seeks to expand the current indication, using daratumumab in combination with lenalidomide (an immunomodulatory agent) and dexamethasone, or bortezomib (a proteasome inhibitor [PI])…

Press Releases

Xycrobe Therapeutics announced today that it has entered into a research agreement with Johnson & Johnson Consumer, Inc. The collaboration, facilitated by Johnson & Johnson Innovation, is focused on further understanding applications of Xycrobe's platform technology developed for the treatment of inflammatory skin diseases. The planned collaboration is intended to…

Press Releases

BioPharma Services, Inc. (BioPharma) is proud to announce that it has acquired key human resource assets along with a list of validated assays from Bioanalytical Laboratory Services (BLS). Over the past 3 years, BLS, led by Lab Director, Nicola Hughes, Ph.D., has built a leading bioanalytical research centre specializing in…